Medline Prices $3.075 Billion Secondary Share Offering

Dow Jones03-05
 

By Megan Cheah

 

Medical- and surgical-product company Medline priced a secondary offering of 75 million shares at $41.00 each.

The shares will be sold by certain stockholders affiliated with private-equity giants Blackstone, Carlyle Group and Hellman & Friedman, as well as a wholly owned unit of the Abu Dhabi Investment Authority, Medline said Wednesday. The offering will raise $3.075 billion.

The selling stockholders have also granted the offering's underwriters a 30-day option to buy up to an additional 11.25 million class A common shares.

The offering is expected to close March 10.

Medline won't receive any proceeds from the share offering, it said. Goldman Sachs and Morgan Stanley are among banks advising on the deal.

The company listed on the Nasdaq in December, raising $6.26 billion in 2025's biggest IPO.

 

Write to Megan Cheah at megan.cheah@wsj.com

 

(END) Dow Jones Newswires

March 05, 2026 00:19 ET (05:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment